Charis E. Teh

2.5k citations

34 papers · 946 indexed · 1 hit paper · h-index 16

Impact in

Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses

Papers in ⓘ

Genetics 9
- Chronic Lymphocytic Leukemia Research 9
- Diabetes and associated disorders 3
Immunology 17
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 12
- Immunotherapy and Immune Responses 4

Co-authors: Daniel H.D. Gray (23 shared papers)Christopher C. Goodnow (7 shared papers)Stephen R. Daley (4 shared papers)Andreas Strasser (9 shared papers)Andrew W. Roberts (9 shared papers)Anselm Enders (4 shared papers)David C.S. Huang (7 shared papers)Rachel Thijssen (6 shared papers)
Journals: Cell Death and Differentiation (6 papers)Blood (4 papers)Blood Advances (2 papers)Experimental Hematology (2 papers)The Journal of Immunology (2 papers)
Partner nations: Australia United States Singapore

In The Last Decade

Charis E. Teh

32 papers receiving 940 citations

Hit Papers

align trajectories log scale

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia 2018 · 276 citations

Peers

Countries citing papers authored by Charis E. Teh

Since Specialization

Citations

This map shows the geographic impact of Charis E. Teh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charis E. Teh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charis E. Teh more than expected).

Fields of papers citing papers by Charis E. Teh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charis E. Teh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charis E. Teh. The network helps show where Charis E. Teh may publish in the future.

Co-authors

The 25 scholars most cited alongside Charis E. Teh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charis E. Teh Line = papers co-authored together Charis E. Teh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia Cancer Discovery ·Piers Blombery, Mary Ann Anderson, Jianan Gong, Rachel Thijssen, Richard W. Birkinshaw, Ella R. Thompson, Charis E. Teh, Tamia Nguyen, Zhen Xu, Christoffer Flensburg, Thomas E. Lew, Ian J. Majewski, Daniel H.D. Gray, David Westerman, Constantine S. Tam, John F. Seymour, Peter E. Czabotar, David C.S. Huang, Andrew W. Roberts Hit paper breakdown →	2018	276
2	ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes Nature Immunology ·Mehmet Yabas, Charis E. Teh, Sandra Frankenreiter, Dennis Lal, Carla M. Roots, Belinda Whittle, Daniel Andrews, Yafei Zhang, Narci Teoh, Jonathan Sprent, Lina E. Tze, Edyta M Kucharska, Jennifer Kofler, Geoffrey C Farell, Stefan Bröer, Christopher C. Goodnow, Anselm Enders	2011	102
3	The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells International Immunology ·J. Wang, Sangmi Lee, Charis E. Teh, Karen Bunting, Lina Ma, M Shannon	2009	85
4	Anti-Islet Autoantibodies Trigger Autoimmune Diabetes in the Presence of an Increased Frequency of Islet-Reactive CD4 T Cells Diabetes ·Diego G. Silva, Stephen R. Daley, Jennifer J. Hogan, Sau K. Lee, Charis E. Teh, Daniel Y. Hu, Kong‐Peng Lam, Christopher C. Goodnow, Carola G. Vinuesa	2011	55
5	Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment Cell Death and Differentiation ·Robyn L. Schenk, Selma Tuzlak, Emma M. Carrington, Yifan Zhan, Susanne Heinzel, Charis E. Teh, Daniel H.D. Gray, Lin Tai, Andrew M. Lew, Andreas Villunger, Andreas Strasser, Marco J. Herold	2017	51
6	Characterization of Blimp-1 function in effector regulatory T cells Journal of Autoimmunity ·Erika Cretney, Patrick S Leung, Stephanie Trezise, Dane M. Newman, Lucille C. Rankin, Charis E. Teh, Tracy L. Putoczki, Daniel H.D. Gray, Gabrielle T. Belz, Lisa A. Mielke, Sheila Dias, Stephen L. Nutt	2018	44
7	Cell death and thymic tolerance Immunological Reviews ·Stephen R. Daley, Charis E. Teh, Daniel Y. Hu, Andreas Strasser, Daniel H.D. Gray	2017	42
8	T-cell regulation by casitas B-lineage lymphoma ( Cblb ) is a critical failsafe against autoimmune disease due to autoimmune regulator ( Aire ) deficiency Proceedings of the National Academy of Sciences ·Charis E. Teh, Stephen R. Daley, Anselm Enders, Christopher C. Goodnow	2010	38
9	ZBTB7B (Th-POK) Regulates the Development of IL-17–Producing CD1d-Restricted Mouse NKT Cells The Journal of Immunology ·Anselm Enders, Sanda Stankovic, Charis E. Teh, Adam P. Uldrich, Mehmet Yabas, Torsten Juelich, John A. Altin, Sandra Frankenreiter, H Bergmann, Carla M. Roots, Konstantinos Kyparissoudis, Christopher C. Goodnow, Dale I. Godfrey	2012	36
10	Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells Cell Death and Differentiation ·Charis E. Teh, Jianan Gong, David Segal, Tania Tan, Cassandra J. Vandenberg, Pasquale L. Fedele, Michael Löw, George Grigoriadis, Simon J. Harrison, Andreas Strasser, Andrew W. Roberts, David C.S. Huang, Garry P. Nolan, Daniel H.D. Gray, Melissa E. Ko	2020	25
11	The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival Leukemia ·Pasquale L. Fedele, Yang Liao, Jianan Gong, Yuan Yao, Mark F. van Delft, Michael Löw, Lin Tai, Marco J. Herold, Jacob T. Jackson, Charis E. Teh, Tania Tan, Lorraine A. O’Reilly, Julie Tellier, George Grigoriadis, David C.S. Huang, Wei Shi, Stephen L. Nutt, Simon N. Willis	2020	21
12	Removing unwanted variation with CytofRUV to integrate multiple CyTOF datasets eLife ·Marie Trussart, Charis E. Teh, Tania Tan, Lawrence Leong, Daniel H.D. Gray, Terence P. Speed	2020	20
13	Visualizing the Role of Cbl-b in Control of Islet-Reactive CD4 T Cells and Susceptibility to Type 1 Diabetes The Journal of Immunology ·Gerard F. Hoyne, Eleanor Flening, Mehmet Yabas, Charis E. Teh, John A. Altin, Katrina L. Randall, Christine B.F. Thien, Wallace Y. Langdon, Christopher C. Goodnow	2011	19
14	The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice Cell Death and Differentiation ·Kerstin Brinkmann, Stephanie Grabow, Craig D. Hyland, Charis E. Teh, Warren S. Alexander, Marco J. Herold, Andreas Strasser	2017	18
15	Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma Oncogene ·Michael A. Dengler, Charis E. Teh, Rachel Thijssen, Lahiru Gangoda, Ping Lan, Marco J. Herold, Daniel H.D. Gray, Gemma L. Kelly, Andrew W. Roberts, Jerry M. Adams	2019	18
16	Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage Science Immunology ·Charis E. Teh, Simon Preston, Alissa K. Robbins, Michael D. Stutz, James P. Cooney, Michelle P. Clark, Antonia N. Policheni, Cody C. Allison, Liana Mackiewicz, Philip Arandjelovic, Gregor Ebert, Marcel Doerflinger, Tania Tan, Lucille C. Rankin, Peggy P. Teh, Gabrielle T. Belz, Axel Kallies, Andreas Strasser, Marc Pellegrini, Daniel H.D. Gray	2022	15
17	Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells Blood Advances ·Charis E. Teh, Hongke Peng, Meng-Xiao Luo, Tania Tan, Marie Trussart, Lauren J. Howson, Chong Chyn Chua, Christine Muttiah, Fiona C. Brown, Matthew E. Ritchie, Andrew H. Wei, Andrew W. Roberts, Vanessa L. Bryant, Mary Ann Anderson, Geoffrey J. Lindeman, David C.S. Huang, Rachel Thijssen, Daniel H.D. Gray	2022	15
18	PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease Proceedings of the National Academy of Sciences ·Antonia N. Policheni, Charis E. Teh, Alissa K. Robbins, Selma Tuzlak, Andreas Strasser, Daniel H.D. Gray	2022	13
19	The acetyltransferase KAT7 is required for thymic epithelial cell expansion, expression of AIRE target genes, and thymic tolerance. PubMed ·Melanie Heinlein, Luke C. Gandolfo, Kelin Zhao, Charis E. Teh, Nghi Nguyen, Jonathan B. Baell, Yael Goldfarb, Jakub Abramson, Johannes Wichmann, Anne K. Voss, Andreas Strasser, Gordon K. Smyth, Tim Thomas, Daniel H.D. Gray	2022	11
20	Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia Blood ·Piers Blombery, Mary Ann Anderson, Jianan Gong, Rachel Thijssen, Richard W. Birkinshaw, Ella R. Thompson, Charis E. Teh, Tamia Nguyen, Zhen Xu, Christoffer Flensburg, Thomas E. Lew, Ian J. Majewski, Daniel H.D. Gray, David Westerman, Constantine S. Tam, John F. Seymour, Peter E. Czabotar, David C.S. Huang, Andrew W. Roberts	2018	9

About Charis E. Teh

Charis E. Teh is a scholar working on Genetics, Immunology, Hematology, Physiology and Oncology, having authored 34 papers that have together received 946 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), Single-cell and spatial transcriptomics (4 papers), Acute Myeloid Leukemia Research (4 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Genetics (234 citations), Immunology (404 citations), Hematology (148 citations), Pathology and Forensic Medicine (164 citations) and Oncology (190 citations). Charis E. Teh has collaborated with scholars based in Australia, United States and Singapore. Frequent co-authors include Daniel H.D. Gray, Christopher C. Goodnow, Stephen R. Daley, Andreas Strasser, Andrew W. Roberts, Anselm Enders, David C.S. Huang, Rachel Thijssen, Jianan Gong and Mary Ann Anderson. Their work appears in journals such as Cell Death and Differentiation, Blood, Blood Advances, Experimental Hematology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact